Jason Springs On Selling His First Startup To Roche For $425 Million And Now Bringing Targeted Therapies To Critically Ill Patients

DealMakers - Jason Springs On Selling His First Startup To Roche For $425 Million And Now Bringing Targeted Therapies To Critically Ill Patients